Mucus models to evaluate nanomedicines for diffusion - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Drug Discovery Today Année : 2014

Mucus models to evaluate nanomedicines for diffusion

Résumé

In the fast-growing field of nanomedicine, mucus is often the first barrier encountered by drug products in the body, and can be the only barrier if it is not overcome by the drug delivery system. Thus, there is a need to design new nanomedicines that are able to diffuse easily across mucus to reach their pharmacological targets. In this design process, mucus diffusion studies are mandatory and have an important role in the selection of the best drug candidates. However, there is currently no standard procedure for diffusion studies across mucus. In this Foundation Review, we discuss the differences observed within mucus models and experimental protocols in diffusion studies, with an emphasis on nanomedicine diffusion.

Fichier principal
Vignette du fichier
mucus_models_to_evaluate_nanomedicines_for_diffusion.pdf (846.34 Ko) Télécharger le fichier
Origine : Accord explicite pour ce dépôt

Dates et versions

hal-03179497 , version 1 (24-03-2021)

Identifiants

Citer

Anne-Claire Groo, Frédéric Lagarce. Mucus models to evaluate nanomedicines for diffusion. Drug Discovery Today, 2014, 19 (8), pp.1097-1108. ⟨10.1016/j.drudis.2014.01.011⟩. ⟨hal-03179497⟩
7 Consultations
177 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More